keloids%20and%20hypertrophic%20scars
KELOIDS AND HYPERTROPHIC SCARS

Keloids and hypertrophic scars are abnormalities in the normal wound healing characterized by greater and more sustained extracellular matrix deposition that develops after any insult in the dermis.

It can affect the patient's quality of life, both physically and psychologically.

Hypertrophic scars are raised fibrous tissue scars that remains within the boundaries of the wound. Hypertrophic scars that resulted from surgery or trauma are called linear hypertrophic scars while those from burn injuries or extensive tissue trauma and/or infections are called widespread hypertrophic scars.

Keloids are elevated fibrous scars that extend beyond the borders of the original wound. Major keloids resulted from minor trauma while for those from genetic predisposition with autosomal-predominant features are called minor keloids.

 

 

Keloids%20and%20hypertrophic%20scars Diagnosis

Classification

Types of Scars
Normal Mature Scar

  • Light-colored, flat scar
  • Contracts slowly over time
  • Results from normal tissue repair

Immature Scar

  • Red, sometimes itchy or painful, & slightly elevated scar in the process of remodelling
  • Many will mature normally over time, become flat, & assume a pigmentation similar to the surrounding skin but they can appear slightly darker or paler
  • Results from normal tissue repair

Hypertrophic Scars

  •  Raised fibrous tissue scar that remains within the boundaries of the wound
  • Usually painful & pruritic
  • Due to excess mechanical stress
  • Commonly occur in wounds across flexion surfaces, the extremities, breasts, sternum & neck
  • Fewer thick collagen fibers & scanty mucoid matrix
  • Usually occur within 1 month of injury
  • Flatten spontaneously & regress w/ time
  • 2 types of hypertrophic scars:
    • Linear hypertrophic scars usually result from surgery or trauma
    • Widespread hypertrophic scars usually result from burn injuries or extensive soft tissue trauma &/or infections

Keloids

  • Elevated fibrous scars that extend beyond the borders of the original wound
  • More common in darker skin types
  • Consist of thick collagen & mucoid matrix
  • May result from minor trauma (major keloid) or genetic predisposition w/ autosomal-predominant features
  • Commonly occur on the sternal skin, shoulders, upper arms, earlobes, & cheeks
  • Appear at 3 months or later
  • Do not regress
  • Usually recur after excision

History

  • History composed of etiology, infection history, associated symptoms like pain, itching, & exposure to radiation & steroid

Physical Examination

  • Physical exam should assess also the surrounding tissue
    • Assess the color, size, texture of the scar; relationship to normal structures; presence of any tethering & contracture; changes w/ movement
Editor's Recommendations
Most Read Articles
20 Jun 2020
The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illnesses. The second day of the symposiumaddressed the topic of schizophrenia management, focusing on treatment goals, the rationale forpartial dopamine D(2) receptor agonism and the use of long-acting injectable (LAI) antipsychotics topromote adherence.
Pearl Toh, 5 days ago
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
4 days ago
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Christina Lau, 2 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.